Market News (Page 1) - TendieTensor

Market News Page 1 of 155 • 3,871 articles

TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

GlobeNewswire Inc. • Rosen Law Firm

TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

11/30/2025 03:00 PM • Rosen Law Firm is investigating potential securities claims for Tandem Diabetes Care shareholders following a voluntary medical device correction that caused a significant stock price drop.

BKSY.WS - The article highlights the company's achievements, industry leadership, and CEO's recognition, indicating strong performance and positive organizational momentum
TNDM - Stock fell 19.9% after announcing a voluntary medical device correction for t:slim X2 insulin pumps that could potentially discontinue insulin delivery, indicating significant product and financial risk

#securities claims #medical device #stock loss #investor rights

Fovia AI to Showcase Universal AI Viewer and Seamless Reporting Integrations at Radiology Reimagined Exhibit, RSNA 2025

GlobeNewswire Inc. • Fovia Ai

Fovia AI to Showcase Universal AI Viewer and Seamless Reporting Integrations at Radiology Reimagined Exhibit, RSNA 2025

11/30/2025 03:00 PM • Fovia AI will demonstrate its F.A.S.T. aiCockpit universal AI viewer at RSNA 2025, showcasing seamless AI integration in radiology workflows through advanced interoperability standards and partnerships with multiple healthcare technology vendors.

GEHC - Mentioned as a partner in demonstration without specific details

#AI #radiology #medical imaging #interoperability #workflow integration

Philips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision

GlobeNewswire Inc. • Philips

Philips launches Verida, world’s first detector-based spectral CT powered by breakthrough AI, to advance diagnostic precision

11/30/2025 12:00 PM • Philips introduced Verida, an advanced AI-powered spectral CT system that offers superior image quality, faster scanning, and reduced radiation dose for medical imaging.

PHG - Company launched an innovative medical imaging technology with multiple advanced features like AI integration, faster scanning, dose reduction, and improved diagnostic precision

#CT #AI #medical imaging #spectral CT #diagnostic technology

DXCM CLASS ACTION FILED: Kessler Topaz Meltzer & Check, LLP Reminds Investors - a Securities Fraud Class Action Lawsuit Has Been Filed Against DexCom, Inc. (DXCM)

GlobeNewswire Inc. • Kessler Topaz Meltzer & Check, Llp

DXCM CLASS ACTION FILED: Kessler Topaz Meltzer & Check, LLP Reminds Investors - a Securities Fraud Class Action Lawsuit Has Been Filed Against DexCom, Inc. (DXCM)

11/30/2025 11:59 AM • A securities class action lawsuit has been filed against DexCom for allegedly making false statements about design changes and reliability of its G6 and G7 continuous glucose monitoring systems, potentially exposing users to health risks.

NVDA - Mentioned in market movers section, no specific analysis provided in the main article
DXCM - The lawsuit alleges multiple serious issues including unauthorized FDA design changes, compromised device reliability, overstated device enhancements, and potential health risks to users, which could significantly damage the company's reputation and financial standing

#securities fraud #class action #medical device #glucose monitoring

Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MRI platform

GlobeNewswire Inc. • Ioannis Panagiotelis

Philips unveils BlueSeal Horizon, industry’s first helium-free 3.0T MRI platform

11/30/2025 11:40 AM • Philips introduces a groundbreaking helium-free 3.0T MRI platform with advanced AI capabilities, designed to improve diagnostic precision, workflow efficiency, and imaging speed for healthcare providers.

TSLA - Mentioned in market movers section, no specific analysis provided in the main article
PHG - Demonstrates technological innovation with a novel MRI platform featuring AI-powered features, helium-free design, and potential to improve medical diagnostics

#MRI #AI #healthcare technology #medical imaging #helium-free

GlobeNewswire Inc. • Na

Meridianbet Launches "Missions" Gamification Platform to Maximize Player Lifetime Value Across Worldwide Markets

11/30/2025 08:43 AM • Meridianbet, a sports betting and gaming operator, launched a new 'Missions' gamification platform designed to increase player retention and long-term profitability through a three-tier reward system across global markets.

TTWO - Tumbled 6.26% as Grand Theft Auto VI release is more than a year away
GMGI - Parent company supporting technological innovation and expanding market reach through subsidiary's new platform

#gamification #sports betting #player engagement #rewards #iGaming

Warren Buffett Bets Big on AI -- He Just Bought 17,846,142 Shares of This Legendary Tech Stock

The Motley Fool • Ryan Vanzo

Warren Buffett Bets Big on AI -- He Just Bought 17,846,142 Shares of This Legendary Tech Stock

11/30/2025 08:31 AM • Berkshire Hathaway acquired 17,846,142 shares of Alphabet, signaling increased interest in AI-related tech stocks. This purchase follows previous investments in Apple and Amazon, suggesting a strategic shift towards technology companies with strong AI potential.

IREN - Jumped 5.18% after beating Q1 revenue estimates
GOOG - Berkshire purchased a significant stake of 17,846,142 shares, valued at $4.3 billion, indicating strong confidence in the company's AI and cloud computing potential

#AI #Warren Buffett #Berkshire Hathaway #tech stocks #investment strategy

התראת מועד לתביעה נגד MLTX: רוזן, עורכי דין מקצועיים למשפט, מעודדים את משקיעי MoonLake Immunotherapeutics לקבל ייעוץ משפטי לפני המועד החשוב בתביעה ייצוגית בניירות ערך – MLTX

GlobeNewswire Inc. • Rosen Law Firm

התראת מועד לתביעה נגד MLTX: רוזן, עורכי דין מקצועיים למשפט, מעודדים את משקיעי MoonLake Immunotherapeutics לקבל ייעוץ משפטי לפני המועד החשוב בתביעה ייצוגית בניירות ערך – MLTX

11/30/2025 02:45 AM • Rosen Law Firm alerts MoonLake Immunotherapeutics investors about an important deadline for a securities class action lawsuit, alleging false or misleading statements about molecular targets and clinical advantages of their therapeutic compounds.

ACHR - Dropped 8.33% after reporting a Q3 loss and announcing airport acquisition
MLTX - The lawsuit alleges the company made false or misleading statements about their therapeutic compounds' molecular targets and clinical advantages, suggesting potential misrepresentation of scientific claims to investors

#securities lawsuit #class action #immunotherapy #investor rights

רוזן, יועץ משפטי מיומן למשקיעים, מעודד את משקיעי Primo Brands Corporation לקבל ייצוג לפני מועד חשוב בתביעה ייצוגית בניירות ערך - PRMB, PRMW

GlobeNewswire Inc. • Rosen Law Firm

רוזן, יועץ משפטי מיומן למשקיעים, מעודד את משקיעי Primo Brands Corporation לקבל ייצוג לפני מועד חשוב בתביעה ייצוגית בניירות ערך - PRMB, PRMW

11/30/2025 02:36 AM • Rosen Law Firm notifies Primo Water and Primo Brands shareholders about an important deadline for a securities class action lawsuit alleging misrepresentations during the merger between Primo Water and BlueTriton Brands.

ACHR.WS - Dropped 8.33% after reporting a Q3 loss and announcing airport acquisition
PRMB - Allegedly misrepresented merger details, claiming transformative operational efficiency and strong financial results that were not accurate

#securities lawsuit #merger #investor rights #class action

The Motley Fool • Motley Fool Staff

The Many Reasons to Roth

11/30/2025 01:36 AM • A detailed discussion about the benefits of Roth retirement accounts, highlighting five key advantages including tax-free withdrawals, no required minimum distributions, potential lower taxes on Social Security, easier early access, and tax-free inheritance for heirs.

EXPE - Soared 15.23% after posting stronger-than-expected Q3 results and raising full-year outlook
BLK - Mentioned in context of a study about low and moderate income Americans investing in stocks, with no direct positive or negative commentary about the company itself

#Roth IRA #retirement planning #tax strategy #investment accounts #retirement savings

DXCM DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM

GlobeNewswire Inc. • Rosen Law Firm

DXCM DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM

11/30/2025 12:35 AM • Rosen Law Firm alerts DexCom investors about a securities class action lawsuit alleging unauthorized design changes to glucose monitoring systems that potentially compromised device reliability and user health risks.

DXCM - Lawsuit alleges the company made unauthorized design changes to G6 and G7 continuous glucose monitoring systems, potentially rendering devices less reliable and presenting material health risks to users, which could lead to regulatory scrutiny and reputational damage

#securities #class action #FDA #glucose monitoring #investor rights

MRX DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Marex Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRX

GlobeNewswire Inc. • Rosen Law Firm

MRX DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Marex Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRX

11/29/2025 11:56 PM • Rosen Law Firm alerts Marex Group investors about a potential securities class action lawsuit involving alleged financial misstatements and inconsistencies during the period of May 16, 2024 to August 5, 2025.

MRX - The lawsuit alleges the company made false or misleading statements, sold financial instruments to itself, had inconsistent financial statements, and potentially misrepresented its business operations and prospects

#securities #class action #financial misstatements #investor rights

JHX DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages James Hardie Industries plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – JHX

GlobeNewswire Inc. • Rosen Law Firm

JHX DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages James Hardie Industries plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – JHX

11/29/2025 11:46 PM • Rosen Law Firm alerts James Hardie Industries investors about a securities class action lawsuit alleging the company misled investors about its North America Fiber Cement segment's performance between May 20-August 18, 2025.

JHX - The lawsuit claims the company falsely represented its demand and inventory levels, potentially misleading investors about the true state of its business segment

#securities class action #investor rights #misleading statements #stock performance

MLTX DEADLINE: ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action – MLTX

GlobeNewswire Inc. • Rosen Law Firm

MLTX DEADLINE: ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action – MLTX

11/29/2025 11:36 PM • Rosen Law Firm is pursuing a securities class action against MoonLake Immunotherapeutics, alleging false and misleading statements about their Nanobody technology's clinical benefits and efficacy during the period of March 10, 2024 to September 29, 2025.

NVDA - Strategic partner with ASML, leading AI semiconductor chip manufacturer with high market demand
MLTX - The lawsuit alleges the company made false statements about its Nanobody technology's clinical advantages, suggesting potential misrepresentation of scientific claims and potential investor harm

#securities lawsuit #Nanobody #class action #investor rights

Bitcoin Munari Presale Advances Toward Next Stage

GlobeNewswire Inc. • Mikael Kotila

Bitcoin Munari Presale Advances Toward Next Stage

11/29/2025 06:00 PM • Bitcoin Munari is completing its second presale round at $0.22, distributing 53% of its 21 million BTCM supply across ten rounds, with plans to launch on Solana in January 2026 and transition to an independent Layer-1 chain in 2027.

COIN - Briefly mentioned as a custody platform for a large Bitcoin transfer, with no specific commentary on its performance

#cryptocurrency #presale #Solana #blockchain #token launch

Should You Buy Cameco While It's Below $90?

The Motley Fool • Courtney Carlsen

Should You Buy Cameco While It's Below $90?

11/29/2025 05:32 PM • Cameco, a leading uranium producer, is experiencing growth potential due to increasing energy demands, particularly from AI data centers, and U.S. government support for nuclear infrastructure development. Despite a recent production forecast reduction, the company remains well-positioned in the nuclear energy market.

CCJ - Strong stock performance (63% gain this year), strategic partnerships with U.S. government, expected earnings growth of 30% annually, and increasing global energy demand supporting nuclear infrastructure

#uranium #nuclear energy #data centers #AI #infrastructure

HashStaking Highlights Institutional Trends as Crypto Market Expands by $11.2 Billion

GlobeNewswire Inc. • Hashstaking Communications Lead

HashStaking Highlights Institutional Trends as Crypto Market Expands by $11.2 Billion

11/29/2025 03:51 PM • HashStaking released an update on its data-driven staking services, highlighting institutional interest in digital assets and multichain strategies. The company introduced an AI-Powered Regional Staking Opportunity Index to analyze global staking conditions and support user understanding of emerging trends.

FATBP - The parent company is actively growing its restaurant portfolio, with Round Table Pizza being one of 18 restaurant brands in its portfolio
BMNR - Reported total asset holdings of $11.2 billion and a 3.85% pre-market share increase, signaling strong institutional interest and financial growth

#staking #digital assets #blockchain #AI analytics #institutional investment

Here's My Top Artificial Intelligence (AI) Stock to Buy in December (Hint: It's Not Broadcom)

The Motley Fool • Harsh Chauhan

Here's My Top Artificial Intelligence (AI) Stock to Buy in December (Hint: It's Not Broadcom)

11/29/2025 02:36 PM • Micron Technology emerges as a promising AI stock with significant growth potential, driven by increasing demand for high-bandwidth memory chips in the AI market, trading at an attractive valuation despite a 166% stock price increase in 2025.

FATBB - The parent company is actively growing its restaurant portfolio, with Round Table Pizza being one of 18 restaurant brands in its portfolio
MU - Strong revenue and earnings growth, favorable demand-supply environment in memory market, attractive valuation (low P/E ratio of 27), and projected 30% annual growth in AI-specific memory chips market through 2030

#AI #semiconductors #memory chips #technology stocks #earnings growth

Herrington Management Launches Educational Resource on Travel Points and Rewards Maximization

GlobeNewswire Inc. • Scott (Spokesperson)

Herrington Management Launches Educational Resource on Travel Points and Rewards Maximization

11/29/2025 12:48 PM • Herrington Management introduced a comprehensive online resource to help consumers understand and maximize airline and hotel loyalty programs, providing insights into strategic point accumulation and redemption across major travel loyalty programs.

LUV - Highlighted for transparent, revenue-based pricing and Companion Pass benefit

#travel points #loyalty programs #travel savings #points redemption

The Ultimate Growth Stock to Buy With $1,000 Right Now

The Motley Fool • Keith Speights

The Ultimate Growth Stock to Buy With $1,000 Right Now

11/29/2025 10:31 AM • Amazon is highlighted as a top growth stock with significant potential in e-commerce, cloud computing (AWS), and emerging technologies like AI and satellite internet services. The company's diverse business segments and global market opportunities make it an attractive investment.

AMZN - Strong growth potential in e-commerce (only 1% global market share), leading cloud computing platform AWS, emerging technologies in AI, quantum computing, and potential robotics innovations

#growth stock #e-commerce #cloud computing #AWS #AI #satellite internet

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of StubHub

GlobeNewswire Inc. • James (Josh) Wilson

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of StubHub

11/29/2025 09:48 AM • Faruqi & Faruqi is investigating potential securities claims against StubHub Holdings following its IPO, alleging material misstatements about financial performance and vendor payment timing that led to significant stock price decline.

STUB - Stock price dropped nearly 56% from IPO price after revealing negative financial metrics, including decreased free cash flow and changes in vendor payment timing, suggesting potential financial mismanagement and misleading investor communications

#securities litigation #IPO #class action #free cash flow #stock price decline

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of James Hardie

GlobeNewswire Inc. • James (Josh) Wilson

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of James Hardie

11/29/2025 08:56 AM • Faruqi & Faruqi, LLP is investigating potential securities claims against James Hardie Industries for allegedly misleading investors about its North America Fiber Cement segment's performance between May and August 2025, resulting in a significant stock price drop.

DUKH - Exceeded earnings expectations, reported 11% EPS growth compared to previous year, narrowed 2025 guidance range, and demonstrated strong strategic planning for future capital investments and energy transition
JHX - The company is accused of making false statements about demand and inventory levels, leading to a 34.44% stock price decline after reporting a 29% profit drop and lower-than-expected earnings projections

#securities litigation #class action #investor losses #financial disclosure

NJDCY INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nidec

GlobeNewswire Inc. • James (Josh) Wilson

NJDCY INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Nidec

11/29/2025 08:53 AM • Nidec Corporation is under investigation for suspected improper accounting practices, leading to significant stock price declines and a Tokyo Stock Exchange special security alert.

DUKpA - Exceeded earnings expectations, reported 11% EPS growth compared to previous year, narrowed 2025 guidance range, and demonstrated strong strategic planning for future capital investments and energy transition
NJDCY - Multiple investigations revealed potential accounting misconduct, stock price dropped substantially (over 68% across several disclosures), and Tokyo Stock Exchange issued a special security alert due to identified internal control system deficiencies

#accounting irregularities #stock investigation #internal control deficiencies

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics

GlobeNewswire Inc. • Faruqi & Faruqi, Llp

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics

11/29/2025 08:51 AM • Tvardi Therapeutics experienced significant stock decline after disappointing Phase 2 clinical trial results for TTI-101 in idiopathic pulmonary fibrosis, with preliminary data showing the study did not meet its goals.

TVRD - Stock plummeted over 80% after unsuccessful clinical trial results, with the study failing to meet its primary objectives and demonstrating ineffective treatment outcomes

#clinical trial #Phase 2 #idiopathic pulmonary fibrosis #stock decline

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

GlobeNewswire Inc. • James (Josh) Wilson

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma

11/29/2025 08:48 AM • Faruqi & Faruqi is investigating potential securities claims against aTyr Pharma after the company's stock dropped 83.25% following disappointing clinical trial results for its drug Efzofitimod, which failed to demonstrate significant steroid reduction in patients.

ATYR - Stock price dropped dramatically by 83.25% after clinical trial results showed minimal efficacy of Efzofitimod in steroid dose reduction, leading to potential securities lawsuit

#securities litigation #class action #pharmaceutical #clinical trial #investor losses